MXPA01004353A - Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. - Google Patents

Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.

Info

Publication number
MXPA01004353A
MXPA01004353A MXPA01004353A MXPA01004353A MXPA01004353A MX PA01004353 A MXPA01004353 A MX PA01004353A MX PA01004353 A MXPA01004353 A MX PA01004353A MX PA01004353 A MXPA01004353 A MX PA01004353A MX PA01004353 A MXPA01004353 A MX PA01004353A
Authority
MX
Mexico
Prior art keywords
chlamydia
strain
host
membrane protein
outer membrane
Prior art date
Application number
MXPA01004353A
Other languages
English (en)
Inventor
Andrew David Murdin
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Publication of MXPA01004353A publication Critical patent/MXPA01004353A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Como resumen de esta exposicion, la presente invencion proporciona un metodo de inmunizacion de un hospedero con acido nucleico, incluyendo al ADN, donde el hospedero incluye humanos, y la inmunizacion se hace contra enfermedades producidas por la infeccion con una cepa de Ch1amydia, especificamente C. pneunomiae, empleando un vector que contiene una secuencia de nucleotidos que codifica para una proteina de membrana externa de 98 kDa de una cepa de Ch1amydia pneumoniae y un promotor para efectuar la expresion del gen de la proteina de membrana externa de 98 kDa en el hospedero. Son posibles modificaciones dentro del alcance de esta invencion.
MXPA01004353A 1998-10-28 1999-10-28 Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. MXPA01004353A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10604698P 1998-10-28 1998-10-28
US13227199P 1999-05-03 1999-05-03
US09/427,533 US6649370B1 (en) 1998-10-28 1999-10-26 Chlamydia antigens and corresponding DNA fragments and uses thereof
PCT/GB1999/003571 WO2000024902A1 (en) 1998-10-28 1999-10-28 Chlamydia antigens and corresponding dna fragments and uses thereof

Publications (1)

Publication Number Publication Date
MXPA01004353A true MXPA01004353A (es) 2002-07-22

Family

ID=27380030

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01004353A MXPA01004353A (es) 1998-10-28 1999-10-28 Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.

Country Status (8)

Country Link
US (2) US6649370B1 (es)
EP (1) EP1124965A1 (es)
JP (1) JP2002528082A (es)
AU (1) AU771974B2 (es)
CA (1) CA2348747A1 (es)
MX (1) MXPA01004353A (es)
NZ (1) NZ511887A (es)
WO (1) WO2000024902A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219453A1 (en) * 1998-03-19 2003-11-27 Smithkline Beecham Biologicals, Sa Vaccines
WO2000034498A1 (en) * 1998-12-04 2000-06-15 University Of Manitoba Two-step immunization procedure against chlamydia infection
WO2001036455A2 (en) * 1999-11-12 2001-05-25 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001036456A2 (en) * 1999-11-15 2001-05-25 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2395499C (en) * 1999-12-22 2011-10-25 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028530A (en) * 1985-01-28 1991-07-02 Xoma Corporation AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques
GB8904762D0 (en) * 1989-03-02 1989-04-12 Glaxo Group Ltd Biological process
US5725863A (en) * 1991-09-06 1998-03-10 The United States Of America As Represented By The Secretary Of Agriculture Polypeptides useful in prevention of chlamydia infection
WO1996009320A1 (en) * 1994-09-20 1996-03-28 Hitachi Chemical Company, Ltd. Antigenic polypeptide of chlamydia pneumoniae
NZ334114A (en) * 1996-07-12 2000-06-23 Univ Manitoba DNA immunization against chlamydia infection comprising a major outer membrane protein (MOMP) or a MOMP fragment linked to a promoter sequence
CA2294651A1 (en) * 1997-06-23 1998-12-30 Svend Birkelund Surface exposed proteins from chlamydia pneumoniae
KR20010032336A (ko) 1997-11-21 2001-04-16 브랑디 빠스깔 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
KR100769103B1 (ko) 1997-11-28 2007-10-23 세로노 제네틱스 인스티튜트 에스.에이. 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
JP2002529069A (ja) 1998-11-12 2002-09-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア クラミジア・ニューモニエのゲノム配列
KR20100132086A (ko) 1998-12-08 2010-12-16 코릭사 코포레이션 클라미디아 감염을 치료 및 진단하기 위한 조성물 및 이를 포함하는 약제학적 조성물 및 진단 키트
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
DE60036698T2 (de) 1999-05-03 2008-07-24 Sanofi Pasteur Ltd., Toronto Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
NZ517952A (en) 1999-09-20 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
CA2395499C (en) 1999-12-22 2011-10-25 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
DE60133190T2 (de) 2000-04-21 2009-04-02 CORIXA CORP., Wilmington Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen
WO2001085972A2 (en) 2000-05-08 2001-11-15 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
CA2414884A1 (en) 2000-07-03 2002-01-10 Chiron S.P.A. Immunisation against chlamydia pneumoniae

Also Published As

Publication number Publication date
WO2000024902A1 (en) 2000-05-04
AU771974B2 (en) 2004-04-08
CA2348747A1 (en) 2000-05-04
JP2002528082A (ja) 2002-09-03
AU6359899A (en) 2000-05-15
US6649370B1 (en) 2003-11-18
EP1124965A1 (en) 2001-08-22
US20020102270A1 (en) 2002-08-01
NZ511887A (en) 2003-11-28

Similar Documents

Publication Publication Date Title
WO2000066739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001046224A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000003685A3 (en) Nitrilase homologs
HUP0402271A2 (hu) Pseudoplectania nigrellá-ból származó antimikrobiális polipeptidek
WO1999033982A3 (en) Human genes and gene expression products i
WO1999038972A9 (en) Human genes and gene expression products ii
JP2002535956A5 (es)
WO2001046225A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075111A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001074863A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075112A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075113A3 (en) Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof
WO2003050236A3 (en) Human genes and gene expression products isolated from human prostate
WO2001075114A3 (en) Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof
EP2172214A3 (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
MXPA01004353A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2001046226A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000006742A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000026239A3 (en) $i(chlamydia) antigens and corresponding dna fragments and uses thereof
MXPA01001639A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
WO2000026237A3 (en) Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof
WO2000006743A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU782261C (en) Novel glycosyltransferase genes
WO1999054436A3 (en) Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof
WO2000006739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof